Intrastromal presbyopia treatment

Article

In a worldwide first, Dr Luis Ruiz presented the preliminary clinical results of an ongoing pilot study concentrating on the non-invasive intrastromal correction of presbyopia.

In a worldwide first, Dr Luis Ruiz presented the preliminary clinical results of an ongoing pilot study concentrating on the non-invasive intrastromal correction of presbyopia.

The Femtec femtosecond laser (20/10 Perfect Vision) applied a customized pattern to the cornea causing a local reorganization of biomechanical forces. In presbyopia, the applied pattern led to a well-defined central steepening of the cornea, resulting in a central increase of refractive power.

“Because the refractive power change is only centrally induced, a significant increase of near vision is evoked, whereas distance vision is only minimally affected,” Dr Ruiz said.

“This non-invasive technique has a huge potential to improve the near vision instantaneously by several lines, and so far there has been no long term downsides observed,” Dr Ruiz said.

He said preliminary results indicate that it may be possible to use this technique on all kinds of intrastromal corrections.

 

To read OTE's full news coverage of the XXVI congress of the European Society of Cataract & Refractive Surgery, please click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.